Almanack Investment Partners’s Inspire Corporate Bond ETF IBD Stock Holding History
Bought
Maintained
Sold
Other funds holding IBD
IA
II
FA
CW
PFG
CFD
LWAM
Almanack Investment Partners's IBD Position: Q4 2022 in Review
Almanack Investment Partners sold out of Inspire Corporate Bond ETF (IBD) in Q4 2022, closing a stake of 188 shares — an estimated $4K sold.
Almanack Investment Partners first reported a position in IBD in Q3 2022 and held it in 1 quarter. The position peaked at $4K in Q3 2022. 51 funds tracked by Wall St. Rank hold IBD as of Q4 2022.
- Almanack Investment Partners reported no remaining Inspire Corporate Bond ETF position as of Q4 2022 after selling out during the quarter.
- Almanack Investment Partners sold 188 Inspire Corporate Bond ETF shares in Q4 2022, an estimated $4K.
- Almanack Investment Partners first reported a position in Inspire Corporate Bond ETF in Q3 2022 and held it in 1 quarter.
- Almanack Investment Partners's Inspire Corporate Bond ETF position peaked at $4K in Q3 2022.
- 51 funds tracked by Wall St. Rank held Inspire Corporate Bond ETF as of Q4 2022.
Based on Almanack Investment Partners's 13F filing for Q4 2022, filed 9 Feb 2023.